The From Testing to Targeted Treatment Program (FT3), established in 2020, is a non-profit, multi-stakeholder global initiative. FT3 is bringing the right people together and building a neutral forum to improve patient outcomes by bringing to life the potential of personalised healthcare and precision medicine, when the patient can benefit from it.
To support our shared vision, we are collaborating with a local multistakeholder team in the Philippines, through a local demonstration pilot that aims to solve local challenges in biomarker testing and targeted therapies. While we aim to improve patient outcomes locally, we look at pilots as a scalable blueprint, to test approaches that can be applied to similar contexts.
This survey aims to understand the challenges faced by you in your work area when it comes to precision medicine, to validate and extend insights that we have gathered from our partners (see here). Your answers are anonymous and will be used to inform a report on the landscape of precision medicine in the Philippines. This survey is intended for healthcare professionals who have experience with precision medicine.
This survey will take approx. 2min and all answers are anonymous.